Microba Life Sciences Ltd
ASX:MAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tclarke PLC
LSE:CTO
|
UK |
|
B
|
Bikurey Hasade Holdings Ltd
TASE:BKRY
|
IL |
|
Ricegrowers Ltd
ASX:SGLLV
|
AU |
|
Sunstone Hotel Investors Inc
NYSE:SHO
|
US |
|
C
|
ChipMOS Technologies Inc
TWSE:8150
|
TW |
|
S
|
Standard Bank Group Ltd
JSE:SBK
|
ZA |
|
G
|
Gujarat Lease Financing Ltd
NSE:GLFL
|
IN |
|
Zinc of Ireland NL
ASX:ZMI
|
AU |
|
Perrigo Company PLC
NYSE:PRGO
|
IE |
|
C
|
Cover 50 SpA
MIL:COV
|
IT |
|
Mackenzie Realty Capital Inc
OTC:MKZR
|
US |
|
Wee-Cig International Corp
OTC:WCIG
|
US |
|
Kyushu Electric Power Co Inc
TSE:9508
|
JP |
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
US |
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
T
|
Tri Viet Asset Management Corporation JSC
VN:TVC
|
VN |
|
G
|
Gogoro Inc
NASDAQ:GGR
|
TW |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Lycopodium Ltd
ASX:LYL
|
AU |
Microba Life Sciences Ltd
Interest Expense
Microba Life Sciences Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Interest Expense
AU$176.7k
|
CAGR 3-Years
47%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Interest Expense
AU$14.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Interest Expense
AU$5.6m
|
CAGR 3-Years
53%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Interest Expense?
Interest Expense
176.7k
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Interest Expense amounts to 176.7k AUD.
What is Microba Life Sciences Ltd's Interest Expense growth rate?
Interest Expense CAGR 5Y
57%
Over the last year, the Interest Expense growth was 155%. The average annual Interest Expense growth rates for Microba Life Sciences Ltd have been 47% over the past three years , 57% over the past five years .
